Curhan Gregory S

Curhan Gregory S is listed in filings as Chief Financial Officer at Serina Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including 2 public disclosures. Recent filings connect the profile to Serina Therapeutics, Inc. (SER). The current snapshot covers public activity from Aug 20, 2024 to May 26, 2026. Reported amounts are shown as $232.5K to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.